HIGHLIGHTS
- who: Jing-Yue Wang and collaborators from the Affiliated Hospital of Weifang Medical University, China have published the paper: GLPu22121 receptor agonists for the treatment of obesity: Role as a promising approach, in the Journal: (JOURNAL)
- how: Showed that BN could reduce glucose levels improve insulin secretion in glucose tolerance tests in a dose-dependent manner and inhibit food intake and gastric emptying.
- future: In the future more prospective randomized controlled clinical studies can be conducted for patients with diabetic obesity or simple obesity. daily. Frontiers in Endocrinology 5 Future research outlook Over . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.